余德才

1.Xianwei Zhou , Chu Qiao , Xuehui Chu , Yajing Yang , Haoran Man , Jingxin Liu , Yunzheng Li , Zhu Xu , Huan Li , Xiaodong Shan , Zaowu Lian , Yanjun Lu , Weihong Wang , Decai Yu *, Xitai Sun , Binghua Li .S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathway.Cell Oncol (Dordr).2025 Oct;48(5):1433-1447. doi: 10.1007/s13402-025-01087-0. PMID: 40658314 PMCID: PMC12528344.

2.Laizhu Zhang,Xiaoli Mai,Binghua Li,Jun Chen*,Decai Yu*.Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma.European Radiology.2025 Jun;35(6):3144-3157.doi: 10.1007/s00330-024-11151-2.PMID:39576331.

3.Tiancheng Xu,Lei Yu,Yajuan Cao,Decai Yu*.Apolipoprotein A1-encoding recombinant adenovirus remodels cholesterol metabolism in tumors and the tumor microenvironment to inhibit hepatocellular carcinoma.Translational Research.2024 Nov 10:275:18-31.PMID:39528003.

4.Binghua Li,Yunzheng Li,Huajun Zhou,Decai Yu*.Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.Hepatology.2024 Feb 1;79(2):289-306.PMID:37540187.PMCID:PMC10789383.

5.Wang Y, Cheng C, Lu Y, Lian Z, Liu Q, Xu Y, Li Y, Li H, Zhang L, Jiang X, Li B, Yu D*. β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma. Cancer Res. 2024 May 15;84(10):1643-1658.PMID:38417136.

6.Yanchao Xu,Yunzheng Li,Yanjun Lu,Decai Yu*.Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.Journal of Hepatocellular Carcinoma.2023 Dec 7.2023:10 2197–2209.PMID:38090626.PMCID:PMC10712262.

7.Laizhu Zhang,Ke Su,Qi Liu,Decai Yu*.Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.BMC cancer.2023 Nov 9;23(1):1081.PMID:37946141.PMCID:PMC10633901.

8.Xiang Jiang,Jin Peng,Yuanyuan Xie,Decai Yu*.Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.Cell Death & Differentiation,2023 June 20. DOI: 10.1038/s41418-023-01186-1.PMID:37419985.PMCID:PMC10406884.

9.Laizhu Zhang,Chunxiao Cheng,Binghua Li,Jun Chen,,Jin Peng,Yajuan Cao,,Yang Yue,Xiaoli Mai,Decai Yu*.Combined clinical features and MRI parameters for the prediction of VEGFR2 in hepatocellular carcinoma patients. Front Oncol.2022 Oct 13;12:961530.PMID:36313714.PMCID:PMC9608502.

10.Yunzheng Li,inghua Li,Yanchao Xu,Liyuan Qian,Tiancheng Xu,Gang Meng,Huan Li,Ye Wang, Laizhu Zhang,Xiang Jiang,Qi Liu,Yuanyuan Xie,,Chunxiao Cheng,Beicheng Sun,Decai Yu*. GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors. Cancer Res.2022 Sep 16;82(18):3223-3235.PMID:35895805.

11.Binghua Li,Yajuan Cao,Yunzheng Li,Chunxiao Cheng,Decai Yu*. Letter to the editor: the inflamed subclass predicts immunotherapy response - external validations. Gut, 2022 Jul 16;gutjnl-2022-328130.PMID:35842234.

12.Binghua Li,Decai Yu*. Letter to the editor: Is the intratumor steatosis a novel biomarker for predicting the efficacy of immunotherapy in hepatocellular carcinoma? Hepatology. 2022 Dec;76(6):E131-E132.PMID:35702874.

13.Tiancheng Xu,Decai Yu*,Weihong Zhou*,Lei Yu*. A nomogram model for the risk prediction of type 2 diabetes in healthy eastern China residents: a 14-year retrospective cohort study from 15,166 participants. EPMA J. 2022 Aug 16;13(3):397-405.PMID:35990778.PMCID:PMC9379230.

14.Weiwei Hu,Shufang Zheng,Haixin Guo,Beiying Dai,Jiaping Ni,Yaohong Shi,Hanrui Bian, Lanxin Li,Yumeng Shen,Mo Wu,Zhoutong Tian,Guilai Liu,Md Amir Hossain,Hongbao Yang, Duowei Wang,Qin Zhang,Jun Yu,Lutz Birnbaumer,Jifeng Feng,Decai Yu*,Yong Yang*. PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity. Hepatology. 2021 Feb;73(2):674-691.PMID:32335942.

15.Liyuan Qian,Yunzheng Li,ajuan Cao,Gang Meng,Jin Peng,Huan Li,Ye Wang,Tiancheng Xu,Laizhu Zhang,Beicheng Sun,Binghua Li,Decai Yu*. Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy. Front Oncol. 2021 Oct 7;11:689068.PMID:34692477.PMCID:PMC8529115.

16.Chen Yan,Bing-Hua Li,Xi-Tai Sun,De-Cai Yu*. Laparoscopic hepatectomy is superior to open procedures for hepatic hemangioma. Hepatobiliary Pancreat Dis Int. 2021 Apr;20(2):142-146.PMID:32980268.

17.Shaohe Wang,Yang Yue,Wenjie Zhang,Qiaoyu Liu,Beicheng Sun,Xitai Sun,Decai Yu*. Dorsal approach with Glissonian approach for laparoscopic right anatomic liver resections. BMC Gastroenterol. 2021 Mar 26;21(1):138.PMID:33771126.PMCID:PMC7995593.

18.Meng G,Li B, Chen A,Zheng M,Xu T,Zhang H,Dong J,Wu J,Yu D*,Wei J*.Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma. Br J Cancer. 2020 Jan;122(1):111-120. doi: 10.1038/s41416-019-0639-7. Epub 2019 Dec 10. PMID: 31819179.PMCID: PMC6964686.

19.Meng G,Fei Z, Fang M,Li B,Chen A,Xu C,Xia M,Yu D*,Wei J*. Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma. Mol Ther Oncolytics. 2019 Mar 27;13:22-34. doi: 10.1016/j.omto.2019.03.004. eCollection 2019 Jun 28. PubMed PMID: 31011625; PubMed Central PMCID: PMC6461577.

20.Sun Qikai,Zhang Zechuan,Lu Yijun Yu Decai* Sun BeiCheng*et al. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells.Hepatology. 2020 Jun;71(6):2033-2049.doi: 10.1002/hep.30978.PMID:31578733.